But Bloomberg News reported Sunday at least two of the medical centers participating in a clinical trial of that drug had suspended their work after Shkreli’s arrest.
Advertisement
Facebook CEO calls WhatsApp suspension ‘sad day for Brazil’
The app that is used by over 90 million people in Brazil – and same percentage of internet users – was quickly unblocked. A court order that temporarily banned WhatsApp in Brazil has been cut short after a judge found the ruling unreasonable.
The KaloBios ouster marks the latest setback for the 32-year-old healthcare industry entrepreneur who has drawn widespread criticism for imposing steep price hikes in the cost of drugs controlled by his companies.
Texas Grand Jury: No Indictments in Sandra Bland’s Death
A grand jury in Texas decided Monday not to proceed with charges against anyone in relation to the death of Sandra Bland. The failure to indict on Monday concerns charges related to Bland’s death and the conduct of jail staffers, he said.
Shkreli became the chief executive of KaloBios in November after obtaining 70 percent of its outstanding shares.
Donald Trump says he hates some journalists, but would ‘never kill’ them
Most recently, Putin called Trump “bright and talented” and “the absolute leader of the presidential race”. That’s how you create a better relationship with Putin”, he said .
United States authorities brought charges against Shkreli on Thursday.
The charges against him stem from his time at drug company Retrophin.
The Martin Shkreli saga continues to unfold.
Mr. Shkreli was arrested last Thursday because of securities fraud. Federal officials are accusing Shkreli of committing fraud at his hedge funds, which carry the MSMB name, then looting his previous biotech company, Retrophin, to pay off the people he defrauded. He faces 20 years in prison if convicted. The price went from $13.50 to $750 per pill. Daraprim is the only approved drug for a life-threatening parasitic infection that mainly strikes pregnant women, cancer patients and AIDS patients.
If you happen to follow Martin Shkreli-the former CEO of a pharmaceutical company who’s now facing a slew of charges for USA securities fraud-on Twitter, you may have noticed some unusual changes in his profile over the weekend.
Speaking to the Wall Street Journal, he claimed “most people don’t know the real Martin Shkreli”, adding that his unpleasant online persona is “a bit of an act”. Shkreli tweeted Saturday: “I am confident I will prevail”. Posts including “I am now a god”, “Anyone want free money?” Shkreli said he saw promise in one of KaloBios’ drug candidates as a possible treatment for a rare form of leukemia.
KalosBios Pharmaceuticals was a faltering business until Mr Shkreli was revealed to be an executive and key shareholder last month, when its shares climbed dramatically. Trading will not resume until the company satisfied Nasdaq’s request for additional information, the exchange said in a statement.
Advertisement
No replacement to serve in Shkreli’s role has been announced by KaloBios. “The allegations against me are baseless and without merit”, he wrote.
